MedTrace Logo

Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients

NCT05467384 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-07-20

No results posted yet for this study

Summary

In this study, Amlodipine has been used to study its effects in newly diagnosed hypertensive patients.

Conditions

Interventions

DRUG

Amlodipine

5mg/day in two divided doses

Sponsors & Collaborators

  • Khyber Medical University Peshawar

    collaborator OTHER

  • Ayub Teaching Hospital

    lead OTHER

Principal Investigators

  • Shahid A Shah, BDS, MPhil · Faculté d'Odontologie, Université de Montpellier

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2017-06-30
Completion
2017-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05467384 on ClinicalTrials.gov